<DOC>
	<DOCNO>NCT02321449</DOCNO>
	<brief_summary>To evaluate effectiveness treatment Circadin base sleep improvement assess modify Questionnaire Scoring Subjective Characteristics Sleep treatment</brief_summary>
	<brief_title>The Effectiveness Circadin Improving Quality Sleep Patients Aged 55 Over</brief_title>
	<detailed_description />
	<criteria>Male female patient age ≥ 55 year suffer nonorganic insomnia accord International Classification Diseases ( ICD10 ) Patients sleep disorder manifest poor sleep quality associate impaired daytime function without one follow criterion : difficulty fall asleep , frequent night awakening , early morning awakening Patients able follow study protocol Patients sign Informed Consent prior initiation observationrelated procedure Patients global score ≤17 inclusively modify Questionnaire Scoring Subjective Characteristics Sleep Patients identify receive treatment Circadin Patients without previous treatment Circadin Hypersensitivity component Circadin Congenital galactose intolerance , glucosegalactose malabsorption , Lapp lactase deficiency Pregnancy lactation Alcohol drug addiction Severe somatic neurological condition , exacerbation thereof , include autoimmune disease renal/hepatic insufficiency Intake psychoactive medicine within last 30 day observational study entry Presence clinically significant anxiety depression assess Hospital Anxiety Depression Scale Presence pain might cause insomnia . Subjects suffer breathe related sleep disorder</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>